Effect of Degranulation Needle With Different Diameters on the Rate Good Embryo in IVF
NCT ID: NCT03810040
Last Updated: 2019-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
400 participants
INTERVENTIONAL
2019-02-28
2019-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Injection of Day 2 Embryo Culture Supernatant Into the Uterine Cavity Didn't Improve Implantation and Pregnancy Rates
NCT00730496
Study of Free DNA Content of Embryo Culture Medium as a Non-Invasive Tool for Embryo Assessment
NCT02480491
Comparison of Two Embryo Transfer Catheters in Patients Undergoing in Vitro Fertilization and Embryo Transfer
NCT02024880
Embryo Transfer With Self-spent Culture Medium
NCT03728140
Mechanical Stimulation Improve the Fertilization in ICSI Cycle
NCT03810001
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Odd-numbered days
Once odd-numbered days the zytoges of IVF cycle were collected. The 140 microns denuding pipette was used.
140 microns denuding pipette
the degranulated needle size was 140 microns
Even-numbered days
Once even-numbered days the zytoges of IVF cycle were collected. The 150 microns denuding pipette was used.
150 microns denuding pipette
the degranulated needle size was 150 microns
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
140 microns denuding pipette
the degranulated needle size was 140 microns
150 microns denuding pipette
the degranulated needle size was 150 microns
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* oocyte number over than 25
22 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tang-Du Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
jin ni
Role: STUDY_DIRECTOR
Tang-Du Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tangdu Hospital
Xi'an, Shaanxi, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
wang ming
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
123456
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.